首页> 外文期刊>Renal failure. >Cardiac arrhythmias and silent myocardial ischemia during hemodialysis.
【24h】

Cardiac arrhythmias and silent myocardial ischemia during hemodialysis.

机译:血液透析过程中的心律失常和无声心肌缺血。

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiac arrhythmias are noted in a significant proportion of chronic renal failure (CRF) patients on hemodialysis (HD), and may contribute to cardiovascular mortality. A number of factors have been implicated in the genesis of these arrhythmias. The role of silent myocardial ischemia (SMI), however, has not been evaluated systematically. We prospectively studied 38 unselected CRF patients on regular HD by continuous Holter monitoring starting 24 hours before HD, lasting through the dialysis session and continued for 20 hours thereafter. The recordings were analyzed for frequency, timing and severity of supraventricular and ventricular arrhythmias and SMI as identified by ST-segment depression. Ventricular arrhythmias during HD were noted in 11 (29%) patients (group I), and were potentially life-threatening (Lown Class III and IVa) in 13%. The remaining 27 patients (group II) had no ventricular arrhythmias during HD. There was no difference in the age, sex ratio, duration of HD, blood pressure, fluctuations in weight, hematocrit, predialysis creatinine, sodium, potassium, calcium or inorganic phosphate levels between patients in the two groups. The number of patients with clinical ischemic heart disease was significantly greater in group I. SMI was noted in 72% and 33% of group I and II patients respectively (p = 0.026). 46% of those with and 25% of those without ST changes during HD developed ventricular arrhythmias during HD. Both SMI and ventricular arrhythmias were noted most frequently during the last hour of dialysis. Hypertension, diabetes mellitus and ischemic heart disease were observed more frequently amongst patients with SMI. Ventricular arrhythmias are detected in a significant proportion of CRF patients on HD. These are probably related to coronary artery disease since silent myocardial ischemia is also noted more frequently during HD in these patients. Further studies incorporating coronary angiography are needed in a larger number of patients to establish a definite causal relationship.
机译:在进行血液透析(HD)的慢性肾功能衰竭(CRF)患者中,有相当一部分患者出现心律失常,并且可能导致心血管疾病的死亡。这些心律不齐的发生与许多因素有关。但是,尚未系统评估沉默性心肌缺血(SMI)的作用。我们通过在HD前24小时开始连续Holter监测,持续到透析期间,并持续20小时,对38例常规HD的未选CRF患者进行前瞻性研究。通过ST段压低来分析记录的室上和室性心律失常和SMI的频率,时间和严重程度。 HD(11%)患者(I组)发生室性心律失常,有13%的患者危及生命(III类和IVa类)。其余27例(II组)在HD期间无心律失常。两组患者的年龄,性别比,HD持续时间,血压,体重波动,血细胞比容,透析前肌酐,钠,钾,钙或无机磷酸盐水平无差异。 I组中有临床缺血性心脏病的患者人数明显增多。I组和II组分别有72%和33%的患者注意到SMI(p = 0.026)。在HD期间有ST改变的患者中有46%和没有ST改变的患者中有25%在HD期间发生了室性心律失常。在透析的最后一个小时内,SMI和室性心律不齐均最常见。在SMI患者中,高血压,糖尿病和缺血性心脏病的发病率更高。在HD上有很大比例的CRF患者中检测到室性心律失常。这些可能与冠状动脉疾病有关,因为这些患者在HD期间也更经常注意到无声心肌缺血。为了建立明确的因果关系,需要对更多的患者进行结合冠状动脉造影的进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号